Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AHPA

This article was originally published in The Tan Sheet

Executive Summary

JAMA July 11 article on herbals and perioperative care "speculative" and unscientific, group says. Study's recommendations to discontinue garlic use seven days prior to surgery "controversial," AHPA contends, saying data were limited to one anomalous case-study. Association maintains JAMA review "might be best repeated by researchers with a stronger knowledge of herbs," but says article's advice to improve patient-physician communication on preoperative herbal use is worthy of "embrace by the medical community" (1"The Tan Sheet" July 16, p. 7)

You may also be interested in...



Valerian, Kava Anesthetic Interaction Potential Cited In JAMA Review

Valerian supplement doses should be tapered off several weeks before surgery to avoid potential withdrawal symptoms in patients who have become physically dependent on the botanical, Michael Ang-Lee, MD, University of Chicago, et al., state in the July 11 Journal of the American Medical Association.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092811

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel